NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 918.50 DKK | +0.47% |
|
+4.20% | +31.57% |
| 13/09 | Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production | RE |
| 12/09 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | ZD |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.47% | +4.20% | +0.93% | -7.32% | +31.57% | +34.50% | +190.94% | +445.67% | +570.44% | 60TCr | ||
| -1.21% | +2.33% | -0.86% | +5.15% | +58.46% | +56.13% | +296.29% | +733.00% | +1,315.21% | 83TCr | ||
| +0.53% | +0.69% | +4.44% | +13.73% | +5.60% | +1.09% | +0.44% | +26.56% | +58.27% | 40TCr | ||
| +0.10% | +0.42% | +0.63% | +15.20% | +25.32% | +26.41% | +82.39% | +175.44% | +235.54% | 34TCr | ||
| +0.53% | -1.68% | +2.01% | -10.52% | +6.27% | +7.04% | +60.67% | +40.25% | +94.56% | 29TCr | ||
| +0.99% | -3.14% | -5.48% | +7.27% | +8.63% | +2.33% | -23.28% | -2.82% | -3.31% | 25TCr | ||
| -1.01% | -5.71% | -7.55% | -4.65% | +12.53% | +10.30% | +46.72% | +73.75% | +163.78% | 24TCr | ||
| -0.28% | -0.45% | -0.12% | +3.32% | +15.66% | +7.60% | +24.57% | +13.27% | +12.05% | 23TCr | ||
| +0.72% | +3.71% | +3.01% | +11.33% | +15.43% | +26.74% | +53.88% | +70.08% | +141.10% | 18TCr | ||
| +0.38% | +2.49% | +1.35% | +6.32% | +1.67% | -14.29% | -34.53% | -20.70% | -0.54% | 17TCr | ||
| +0.58% | -1.09% | +5.95% | +19.63% | +15.20% | +0.96% | +26.37% | +30.01% | +19.00% | 14TCr | ||
| +0.51% | +5.20% | +11.69% | +27.28% | +2.22% | +7.04% | +17.54% | +24.49% | -20.11% | 10TCr | ||
| +1.84% | +0.88% | +1.49% | +19.25% | -4.25% | -17.41% | -20.90% | -0.61% | -2.25% | 9.96TCr | ||
| -0.31% | -1.09% | +2.25% | +1.81% | +12.64% | +9.84% | -7.59% | -20.32% | -9.31% | 8.76TCr | ||
| -1.64% | +2.17% | +5.36% | +35.68% | +25.80% | +50.17% | +60.08% | +168.80% | +527.06% | 7.87TCr | ||
| +0.86% | -9.05% | -10.91% | -5.29% | +32.62% | +24.82% | +84.78% | +122.01% | +732.70% | 6.95TCr | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 6.37TCr | ||
| +1.47% | +0.87% | +5.16% | +21.21% | +22.21% | +19.67% | - | - | - | 4.71TCr | ||
| -2.18% | -3.14% | -2.34% | -0.12% | +2.05% | -13.90% | +11.39% | +9.27% | -13.93% | 4.67TCr | ||
| -0.44% | +0.83% | +5.34% | +6.85% | -1.02% | +5.12% | -4.34% | -17.98% | +455.20% | 4.01TCr | ||
| Average | +0.10% | -0.33% | +1.18% | +8.74% | +15.19% | +12.85% | +48.08% | +103.90% | +237.53% | 21.63TCr | |
| Weighted average by Cap. | -0.00% | +0.48% | +0.55% | +5.50% | +23.68% | +21.71% | +103.72% | +241.46% | +414.56% |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition